What types of agencies buy Regulatory Science services?

Federal agencies across all departments procure Regulatory Science services, including the Department of Defense, Department of Veterans Affairs, General Services Administration, and civilian agencies. State and local governments also issue Regulatory Science contracts through their own procurement portals.

How do I find Regulatory Science contracts with SamSearch?

Use SamSearch to browse pre-classified opportunities in one place, with AI-powered filtering by agency, set-aside, and deadline.

Are there set-aside contracts for small businesses in Regulatory Science?

Yes. Many Regulatory Science contracts are set aside for small businesses, including 8(a), WOSB, SDVOSB, and HUBZone firms. Use SamSearch's set-aside filters to find contracts your business qualifies for.

How competitive are Regulatory Science government contracts?

Competition varies by contract size and type. Large IDIQ vehicles in Regulatory Science can attract dozens of bidders, while small open-market solicitations may have only a few. Monitoring active solicitations and building agency relationships early improves win rates.

Contract Category

Regulatory Science Government Contracts

9 government contract opportunities classified as Regulatory Science. Updated daily.

5 federal4 forecastsUpdated daily

Federal Opps

Federal contracts

SLED Opps

—

State, local & education contracts

Forecasts

Agency pipeline forecasts

Total

All sources combined

5 federal contract opportunities classified as Regulatory Science.

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

Archived

AI Summary

The FDA is seeking proposals for advanced research and development in regulatory science through a Broad Agency Announcement (BAA). This opportunity aims to enhance scientific knowledge and innovation to support the FDA's mission. Proposals are due by 20 January 2026, and the announcement has been updated to version 2.…

Posted Jan 16, 2026Due Feb 24, 2026Special NoticeNAICS 541714Sol: FDABAA-26-00123

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FY25 FDA BROAD AGENCY ANNOUNCEMENT (BAA) FOR ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE

Archived

AI Summary

The FDA is seeking proposals for advanced research and development in regulatory science through its FY25 Broad Agency Announcement (BAA), with a response deadline of March 4, 2025, at 11:59 PM EST. This opportunity aims to enhance scientific knowledge in specific research areas relevant to the FDA's mission. Intereste…

Posted Feb 26, 2025Due Mar 5, 2025Special NoticeNAICS 541714Sol: FDABAA-25-00123

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FY23 FDA BROAD AGENCY ANNOUNCEMENT (BAA) FOR ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE

Archived

AI Summary

The FDA has issued a Broad Agency Announcement for advanced research and development in regulatory science. Proposals are invited from qualified entities, with full proposals already sent to applicable submitters. This opportunity focuses on health and human services, particularly in the context of regulatory science a…

Posted May 18, 2023Due Jan 23, 2023SolicitationSol: FDABAA-23-00123

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FY22 FDA BROAD AGENCY ANNOUNCEMENT (BAA) FOR ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE

Archived

AI Summary

The FDA is seeking proposals for basic and applied research to enhance regulatory science and innovation. This Broad Agency Announcement (BAA) invites submissions that align with the agency's mission to improve public health through advanced research and development initiatives.

Posted Jan 20, 2022Due Jan 21, 2022SolicitationSol: FDABAA-22-00123

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FY21 FDA BROAD AGENCY ANNOUNCEMENT (BAA) FOR ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE

Archived

AI Summary

The FDA has issued a Broad Agency Announcement for advanced research and development in regulatory science. This opportunity invites white papers addressing innovative approaches in health and human services. Interested parties should submit their proposals to the specified FDA inbox as outlined in the announcement.

Posted May 26, 2021Due Jan 28, 2021SolicitationSol: FDABAA-21-00123

View details→